Lehrstuhl für Urologie

Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC) (2019) Eckstein M, Hartmann A, Strissel P, Strick R, Wach S, Taubert H, Wullich B, et al. Conference contribution Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism (2019) Kappler M, Pabst U, Weinholdt C, Taubert H, Rot S, Kaune T, Kotrba J, et al. Journal article Development and Usability Analysis of a Multimedia eConsent Solution (2019) Schneiderheinze H, Prokosch HU, Apel H, Bellut L, Wullich B, Trollmann R, Schüttler C Book chapter / Article in edited volumes Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma (2019) Weyerer V, Weisser R, Moskalev E, Haller F, Stoehr R, Eckstein M, Zinnall U, et al. Journal article Large nested variant of urothelial carcinoma: a prime example of a FGFR3-mutated, luminal tumour (2019) Weyerer V, Eckstein M, Comperat E, Juette H, Allory Y, Stoehr R, Wullich B, et al. Conference contribution Tumour immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes (2019) Eckstein M, Strissel P, Pfannstiel C, Chiappinelli K, Sikic D, Wach S, Taubert H, et al. Conference contribution Treatment of benign prostatic hyperplasia in geriatric patients-use and limitations of existing guidelines (2019) Schoeb DS, Wullich B, Duerschmied D, Heimbach B, Heupel-Reuter M, Gross AJ, Wilhelm K, et al. Journal article Analytical and inter-observer comparability of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in advanced clear cell renal cell carcinoma (CCRCC) (2019) Sommer U, Eckstein M, Ammann J, Braunschweig T, Macher-Goeppinger S, Schwamborn K, Hieke-Schulz S, et al. Conference contribution Protein levels of Piwi-like 1 and-2 protein are prognostic factors for muscle invasive urothelial bladder cancer patients (2019) Eckstein M, Jung R, Weigelt K, Sikic D, Stöhr R, Geppert CI, Agaimy A, et al. Conference contribution Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo (2019) Wach S, Brandl M, Borchardt H, Weigelt K, Lukat S, Nolte E, Al-Janabi O, et al. Journal article